Biotinyl Tripeptide-1
Biotinyl Tripeptide-1 is used or marketed in topical cosmetic formulations, with peptide-specific clinical evidence that is limited or formulation-dependent.
- Human evidencen/a
- Animal evidencen/a
- Mechanisticn/a
- Safety knowledgen/a
- Editorial confidence2/5
Evidence Snapshot
- Overall
- 0/5None identified
- Human
- 0/5None identified
- Animal
- 0/5None identified
- In-vitro
- 0/5None identified
- Safety
- 0/5None identified
Scientific identity
- Peptide family
- Topical cosmetic peptide
- Entity class
- Cosmetic peptide
Biotinyl Tripeptide-1 entered research or commercial use through work on its proposed biological, cosmetic or therapeutic activity.
Proposed Mechanisms
- not-yet-documentedpending-editorial-review
- Collagen synthesis →limited
Reported / Studied Uses
- Skin Ageing / WrinklesEvidence · insufficient
Human Evidence
Robust independent controlled human evidence specific to this peptide was not identified for this Atlas entry.
Animal Evidence
No robust animal evidence supporting routine cosmetic use was identified.
Safety & Unknowns
Regulatory Status
| Country | Status | Notes |
|---|
Community Observations
References
- No verified references linked yet. Editors will add primary sources.
Full Disclaimer
This page is for educational information only. It does not constitute medical advice, diagnosis, treatment, dosing guidance, or a recommendation to use any peptide, medicine or research chemical. Many peptides discussed on Atlas are not approved for human use in most jurisdictions and may have limited or unknown long-term safety data.
Community observations shown on this page are anonymised, moderated and observational only. They do not establish safety or effectiveness.
Always consult a qualified healthcare professional before making decisions about your health. See medical disclaimer and methodology.